Immunosuppressant strategies for intestinal transplantation: a review of a tolerogenic regimen.
Intestinal, combined liver-intestinal, and multivisceral transplantation are now considered the standard of care for children and adults with permanent intestinal failure. Early attempts at intestinal transplantation were discouraging because of the high incidence of technical complications, rejection, and infection. Advances in the field of transplantation, including the introduction of tacrolimus, improved surgical techniques, and improvements in postoperative care, have led to a renewed interest in intestinal transplantation since 1990. The most significant achievement, however, has been the effective control of rejection and life-threatening infections. This article focuses on the experience to date of innovative strategies that induce lymphocyte depletion and reduction in the incidence of rejection. In this setting, low-maintenance immunosuppression is clinically achievable with an acceptable rate of allograft rejection. Subsequently, the long-term complications of immunosuppression are significantly reduced with achievement of better long-term survival, and an overall improvement in the quality of life.
Flynn
Bridget
B
University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Park
Beverly Kosmach
BK
Bond
Geoffrey
G
McGhee
William
W
Mazariegos
George
G
Sindhi
Rakesh
R
Reyes
Jorge
J
Abu-Elmagd
Kareem
K
D006084:Graft Rejection / Q000517:prevention & control; D006085:Graft Survival; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods*; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D007422:Intestines / Q000637:transplantation*; D015996:Survival Rate
D007166:Immunosuppressive Agents